CDC Releases National Human Exposure Data on 27 Pollutants

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 6
Volume 10
Issue 6

WASHINGTON-National exposure data for 27 contaminants are detailed in the first National Report on Human Exposure to Environmental Chemicals, assembled and released by the Centers for Disease Control and Prevention (CDC). Unlike studies that estimate population exposures by measuring air, water, and soil samples, the new data represent direct measurements of chemicals in blood and urine samples. The samples were collected in 1999 as part of CDC’s periodic National Health and Nutrition Examination Survey.

WASHINGTON—National exposure data for 27 contaminants are detailed in the first National Report on Human Exposure to Environmental Chemicals, assembled and released by the Centers for Disease Control and Prevention (CDC). Unlike studies that estimate population exposures by measuring air, water, and soil samples, the new data represent direct measurements of chemicals in blood and urine samples. The samples were collected in 1999 as part of CDC’s periodic National Health and Nutrition Examination Survey.

CDC had previously assessed the population exposure of only three of the substances listed in the new report—lead, cadmium, and cotinine. Cotinine, a byproduct of the breakdown of nicotine after it enters the body, serves as a marker for a person’s exposure to tobacco smoke, either primary or secondary.

The report showed a 75% decrease in serum cotinine levels of nonsmokers in the United States, documenting "a dramatic reduction in exposure of the US population to environmental tobacco smoke since 1991," said Richard Jackson, MD, director of CDC’s National Center for Environmental Health.

Other metals covered in the report include mercury, cobalt, antimony, barium, beryllium, cesium, molybdenum, platinum, thallium, tungsten, and uranium. The pesticide data include six metabolites of organophosphate pesticides, which represent exposure to 28 pesticides. Also included are data on seven phthalate metabolites, found in many plastics.

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content